We continue to work on ChIP-sequencing. Considering this will be the first time we will be performing a genome wide search for FGFR3 target genes, we have to do a lot of troubleshooting and run preliminary experiments to confirm our experimental conditions. We have made considerable progress and will be performing initial ChIP-sequencing experiments.
On the other hand, we are also making progress in developing transgenic mice that will be used to discover effects of FGFR3 mutations on bone growth.
